Gaslightwala Appointed CEO at Akari Therapeutics
Portfolio - People | Mar 20, 2025 | EIN
Akari Therapeutics Plc, a biotechnology company specializing in next-generation precision bi-functional antibody drug conjugates (ADCs) for cancer treatment, has announced the appointment of Abizer Gaslightwala as their new President and Chief Executive Officer effective April 21, 2025. Mr. Gaslightwala joins Akari from Jazz Pharmaceuticals, where he successfully managed a portfolio with annual sales of $1 billion. Current President and CEO, Dr. Samir R. Patel, will remain on the company's board. Gaslightwala brings 25 years of experience in pharmaceuticals, having held roles at Amgen, Pfizer, and Johnson & Johnson. He is seen as a strategic leader to propel Akari's innovative ADC platform, which shows promise in overcoming current ADC shortcomings. Akari is committed to advancing ADC candidates for treating cancer and plans to collaborate with leading immunotherapy companies in innovating cancer treatment paradigms. The company looks forward to leveraging Mr. Gaslightwala's unique skillset for continued growth and innovation.
Sectors
- Biotechnology
- Pharmaceuticals
Geography
- United States – The article mentions that Mr. Gaslightwala's appointment comes after his role at Jazz Pharmaceuticals, a U.S-based company.
- United Kingdom – Akari Therapeutics is noted as a UK-based company actively developing new treatments.
Industry
- Biotechnology – Akari Therapeutics operates in the biotechnology sector, focusing on developing ADCs for cancer treatment.
- Pharmaceuticals – The article discusses companies like Jazz Pharmaceuticals and Mr. Gaslightwala's past roles in major pharmaceutical companies such as Amgen, Pfizer, and Johnson & Johnson.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Akari Therapeutics Plc | Company Mentioned | Company | Biotechnology company focused on developing next-generation precision bi-functional ADCs for cancer treatment. |
| Abizer Gaslightwala | President and CEO | Person | Newly appointed President and CEO of Akari Therapeutics, with an extensive background in pharmaceuticals. |
| Samir R. Patel, M.D. | Current President and CEO | Person | Outgoing CEO of Akari Therapeutics, transitioning to a board role. |
| Jazz Pharmaceuticals | Previous Employer | Company | Pharmaceutical company where Abizer Gaslightwala managed a successful oncology portfolio. |
| Amgen Inc. | Former Employer | Company | One of the companies where Mr. Gaslightwala held leadership roles. |
| Pfizer Inc. | Former Employer | Company | One of the companies where Mr. Gaslightwala held leadership roles. |
| Johnson & Johnson | Former Employer | Company | One of the companies where Mr. Gaslightwala held leadership roles. |